Analyzing Enzalutamide Patient-Reported Outcomes and QOL in the EMBARK Trial: Stephen Freedland, MD

from Oncology Data Advisor · host i3 Health

This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!

Episode metadata supplied by the publisher feed · Published Jun 20, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Analyzing Enzalutamide Patient-Reported Outcomes and QOL in the EMBARK Trial: Stephen Freedland, MD

0:00 12:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Data Advisor?

This episode is 12 minutes long.

When was this Oncology Data Advisor episode published?

This episode was published on June 20, 2024.

Can I download this Oncology Data Advisor episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!